Detalhe da pesquisa
1.
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells.
Br J Cancer
; 130(7): 1196-1205, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287178
2.
The role of inner nuclear membrane proteins in tumourigenesis and as potential targets for cancer therapy.
Cancer Metastasis Rev
; 41(4): 953-963, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205821
3.
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer.
Prostate
; 83(7): 628-640, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811381
4.
Targeting the COMMD4-H2B protein complex in lung cancer.
Br J Cancer
; 129(12): 2014-2024, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914802
5.
Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surface.
Phys Chem Chem Phys
; 25(36): 24657-24677, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665626
6.
Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity.
Nucleic Acids Res
; 49(6): 3294-3307, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660778
7.
Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 24(13)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445722
8.
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 381(21): 2020-2031, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562796
9.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658845
10.
Do ethnic patients report longer lung cancer intervals than Anglo-Australian patients?: Findings from a prospective, observational cohort study.
Eur J Cancer Care (Engl)
; 30(6): e13492, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312918
11.
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Lancet Oncol
; 21(9): 1213-1223, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888453
12.
Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Mol Cancer
; 19(1): 16, 2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987050
13.
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer.
Br J Cancer
; 123(4): 591-603, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32439936
14.
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
J Transl Med
; 18(1): 99, 2020 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087721
15.
Nivolumab plus ipilimumab in non-small-cell lung cancer.
Future Oncol
; 15(19): 2287-2302, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31066582
16.
A structural analysis of DNA binding by hSSB1 (NABP2/OBFC2B) in solution.
Nucleic Acids Res
; 44(16): 7963-73, 2016 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27387285
17.
EV, Microvesicles/MicroRNAs and Stem Cells in Cancer.
Adv Exp Med Biol
; 1056: 123-135, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754178
18.
hSSB1 associates with and promotes stability of the BLM helicase.
BMC Mol Biol
; 18(1): 13, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506294
19.
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.
Br J Cancer
; 116(2): 175-185, 2017 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28006816
20.
Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
Cell Immunol
; 319: 35-42, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28735814